APA (7th ed.) Citation

C, H., HD, W., RAH, S., A, B., CP, C., JS, H., . . . L, W. (2017). Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. Journal of the American Heart Association, 6(10), . https://doi.org/10.1161/JAHA.116.005077

Chicago Style (17th ed.) Citation

C, Held, et al. "Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial." Journal of the American Heart Association 6, no. 10 (2017). https://doi.org/10.1161/JAHA.116.005077.

MLA (9th ed.) Citation

C, Held, et al. "Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial." Journal of the American Heart Association, vol. 6, no. 10, 2017, https://doi.org/10.1161/JAHA.116.005077.